Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

Condition(s) studied

Investigational drug(s) / intervention(s)

Study summary

Motive:

In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients.

Goal:

To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Eligibility

Primary outcome measure(s)

• Acute toxicity — Highest during and within 2 weeks after last day of radiation therapy
  esophagitis (Common Terminology Criteria for Adverse Events, version 4.0)
• Late toxicity — Highest within one year after last day of radiation therapy
  esophagitis (Common Terminology Criteria for Adverse Events, version 4.0); pneumonitis (Common Terminology Criteria for Adverse Events, version 4.0)

Trial sites (1)

More University Medical Center Groningen trials in the Netherlands

Other trials for the same condition